Back to search
FDAFDA · Food and drugs·Recall number Z-0928-2014

XiO RTP System. Used to create treatment plans for any cancer patient for whom external beam radiation therapy or brachytherapy has been prescribed.

Published February 12, 2014 · Recall initiated: November 25, 2013

Summary

FDA records medical device Class II recall Z-0928-2014, published February 12, 2014 and initiated November 25, 2013. Recalling firm: Elekta, Inc.; Status: Terminated; Reported quantity: 1424; Lot: MUJ. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

When bolus is present, the Effective Depth (with bolus) to the weight point returned on the Source Data Report is incorrect.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Elekta, Inc.
Distributor
Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of AL, AK, AZ, CA, CO, CT, DE, FL, GA, IL, IN, KS, KY, LA, ME, MD, MI, MN, MS, MO, MT, NE, NV, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, QA, WA, WV, WI, and WY, and the countries of Albania, Algeria, Argentina, Austria, Australia, Bosnia, Bulgaria, Belgium, Bahrain, Brazil, Belarus, Botswana, Bangladesh, Canada, China, Columbia, Costa Rica, Croatia, Cuba, Cyprus, Chile, Czech Republic, Ecuador, Egypt, Estonia, France, Finland, Gabon, Germany, Great Britain, Greece, Guatemala, Hungary, India, Indonesia, Italy, Ireland, Israel, Iraq, Jordan, Japan, Kosovo, Kuwait, Lithuania, Libya, Latvia, Morocco, Malaysia, Malta, Mexico, Myanmar, Netherland, New Zealand, Pakistan, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, Slovakia, South Africa, South Korea, Spain, Sudan, Syria, Taiwan, Thailand, Turkey, Turkmenistan, Ukraine, Venezuela, and Vietnam.
Lot
MUJ
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was XiO RTP System. Used to create treatment plans for any cancer patient for whom external beam radiation therapy or brachytherapy has been prescribed. recalled?

Yes. FDA published recall Z-0928-2014 on February 12, 2014. Reported hazard: When bolus is present, the Effective Depth (with bolus) to the weight point returned on the Source Data Report is incorrect.

What should I do if I have this product?

Voluntary: Firm initiated · Letter